Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 08 04:00PM ET
11.24
Dollar change
+0.14
Percentage change
1.26
%
Index- P/E- EPS (ttm)-0.49 Insider Own31.19% Shs Outstand159.85M Perf Week-0.97%
Market Cap1.81B Forward P/E22.08 EPS next Y0.51 Insider Trans-0.11% Shs Float110.71M Perf Month-2.01%
Income-78.68M PEG- EPS next Q0.11 Inst Own64.02% Short Float3.91% Perf Quarter-19.02%
Sales363.55M P/S4.97 EPS this Y-4.79% Inst Trans-0.26% Short Ratio3.96 Perf Half Y-39.28%
Book/sh6.49 P/B1.73 EPS next Y24.36% ROA-5.06% Short Interest4.33M Perf Year-21.84%
Cash/sh1.40 P/C8.05 EPS next 5Y10.86% ROE-7.35% 52W Range10.35 - 19.87 Perf YTD-36.10%
Dividend Est.- P/FCF27.15 EPS past 5Y-10.50% ROI-5.84% 52W High-43.43% Beta1.49
Dividend TTM- Quick Ratio2.61 Sales past 5Y16.90% Gross Margin45.30% 52W Low8.60% ATR (14)0.51
Dividend Ex-Date- Current Ratio2.61 EPS Y/Y TTM-506.84% Oper. Margin-3.03% RSI (14)46.65 Volatility3.46% 4.25%
Employees1391 Debt/Eq0.30 Sales Y/Y TTM3.26% Profit Margin-21.64% Recom2.27 Target Price16.50
Option/ShortYes / Yes LT Debt/Eq0.29 EPS Q/Q-366.33% Payout- Rel Volume0.86 Prev Close11.10
Sales Surprise-2.81% EPS Surprise-31.77% Sales Q/Q3.17% EarningsAug 06 AMC Avg Volume1.09M Price11.24
SMA201.89% SMA50-7.65% SMA200-27.63% Trades Volume934,799 Change1.26%
Date Action Analyst Rating Change Price Target Change
Sep-27-24Upgrade UBS Neutral → Buy $16
Apr-10-24Upgrade KeyBanc Capital Markets Sector Weight → Overweight $23
Apr-04-24Initiated JMP Securities Mkt Perform
Feb-26-24Initiated Leerink Partners Market Perform $19
Dec-07-23Initiated UBS Neutral $17
Dec-05-23Initiated KeyBanc Capital Markets Sector Weight
Aug-22-23Downgrade Jefferies Buy → Hold $24.50 → $17
Aug-10-23Downgrade William Blair Outperform → Mkt Perform
Apr-12-23Initiated Stephens Overweight $28
Apr-03-23Downgrade Barclays Overweight → Equal Weight $25
Oct-02-24 04:15PM
Sep-27-24 07:20PM
Sep-24-24 08:00AM
Sep-18-24 08:00AM
Sep-17-24 11:02AM
07:03PM Loading…
Aug-28-24 07:03PM
Aug-21-24 04:15PM
Aug-15-24 04:15PM
Aug-12-24 03:57AM
Aug-07-24 12:25PM
Aug-06-24 06:25PM
04:15PM
Jul-09-24 04:45PM
Jul-02-24 04:15PM
Jun-17-24 08:00AM
04:15PM Loading…
May-29-24 04:15PM
May-21-24 08:00AM
May-09-24 02:45PM
May-08-24 01:16PM
05:48AM
04:13AM
May-07-24 06:40PM
05:59PM
04:15PM
May-06-24 03:19AM
Apr-16-24 08:00AM
Apr-09-24 04:15PM
Apr-04-24 07:01PM
Mar-02-24 08:41AM
Mar-01-24 07:10AM
06:05PM Loading…
Feb-29-24 06:05PM
04:52PM
04:10PM
Feb-01-24 04:30PM
Jan-31-24 11:03PM
Dec-13-23 04:30PM
Nov-21-23 04:30PM
Nov-10-23 01:22PM
Nov-09-23 10:41AM
Nov-08-23 07:15PM
04:10PM
Oct-31-23 12:00PM
Oct-20-23 08:34AM
Oct-11-23 04:15PM
Sep-19-23 08:15AM
Sep-13-23 05:01AM
Aug-29-23 04:15PM
08:15AM
Aug-23-23 01:43PM
Aug-22-23 02:41AM
Aug-12-23 08:07AM
Aug-11-23 06:09AM
Aug-10-23 09:41AM
Aug-09-23 04:15PM
Aug-03-23 09:00PM
Aug-02-23 08:55AM
Jul-27-23 09:47AM
Jul-13-23 04:30PM
Jun-02-23 04:15PM
May-16-23 06:50AM
May-09-23 06:53AM
May-08-23 06:35PM
04:15PM
May-02-23 10:02AM
04:24AM
May-01-23 02:03PM
10:01AM
07:13AM
Apr-28-23 07:15AM
Apr-27-23 08:00AM
Apr-10-23 04:30PM
Apr-06-23 12:19PM
Apr-05-23 12:25PM
11:42AM
Apr-04-23 12:43PM
Mar-29-23 12:01PM
Mar-28-23 03:00PM
Mar-27-23 11:35AM
Mar-15-23 05:41PM
10:00AM
Mar-14-23 09:40AM
Mar-09-23 12:20PM
08:00AM
Mar-08-23 07:04AM
Mar-07-23 08:00AM
Mar-02-23 07:43AM
Mar-01-23 06:25PM
04:16PM
04:15PM
Feb-27-23 04:30PM
Feb-01-23 04:30PM
Jan-09-23 11:40AM
Jan-04-23 07:31AM
Dec-23-22 06:35PM
Dec-08-22 04:30PM
Nov-26-22 09:01PM
Nov-11-22 04:28PM
Nov-07-22 07:05PM
04:15PM
08:00AM
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONSOct 07 '24Sale11.035,40959,66150,091Oct 08 04:17 PM
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONSOct 04 '24Option Exercise0.007,151057,242Oct 07 04:42 PM
SMITH PATRICK FOfficerOct 07 '24Proposed Sale11.035,40959,661Oct 07 09:48 AM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFSep 09 '24Sale11.2951,224578,31999,704Sep 10 05:01 PM
Pedersen Leif EOfficerSep 09 '24Proposed Sale11.2951,224578,450Sep 09 04:27 PM
WALSH MATTHEW MDirectorMay 21 '24Option Exercise0.008,6630185,631May 23 04:45 PM
Killefer NancyDirectorMay 21 '24Option Exercise0.008,663024,161May 23 04:40 PM
Crane Rosemary ADirectorMay 21 '24Option Exercise0.008,663017,987May 23 04:35 PM
Collins CynthiaDirectorMay 21 '24Option Exercise0.008,663024,161May 23 04:29 PM
CASHMAN JAMES E IIIChairmanMay 21 '24Option Exercise0.008,6630456,512May 23 04:22 PM
BROSHY ERANDirectorMay 21 '24Option Exercise0.008,663023,023May 23 04:17 PM
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONSApr 02 '24Sale16.8514,427243,16150,091Apr 04 04:45 PM
Traynor Richard M.SVP AND GENERAL COUNSELApr 01 '24Option Exercise0.0013,2950178,800Apr 03 05:08 PM
Traynor Richard M.SVP AND GENERAL COUNSELApr 01 '24Sale18.003,00054,000173,524Apr 03 05:08 PM
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONSApr 01 '24Option Exercise0.0016,498067,208Apr 03 05:07 PM
SHERMAN NICOLETTE DCHIEF HUMAN RESOURCES OFFICERApr 01 '24Option Exercise0.008,219025,684Apr 03 05:05 PM
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFFApr 01 '24Option Exercise0.0016,4980152,840Apr 03 05:03 PM
Gallagher John ECHIEF FINANCIAL OFFICERApr 01 '24Option Exercise0.0027,295022,545Apr 03 05:02 PM
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWAREApr 01 '24Option Exercise0.0016,4980293,867Apr 03 05:00 PM
Feehery William FCHIEF EXECUTIVE OFFICERApr 01 '24Option Exercise0.0069,79902,263,269Apr 03 04:44 PM
Traynor Richard M.SVP AND GENERAL COUNSELMar 04 '24Sale18.283,00054,840162,368Mar 05 04:45 PM
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONSFeb 20 '24Sale18.005,00090,00054,975Feb 21 04:40 PM
Traynor Richard M.SVP AND GENERAL COUNSELFeb 12 '24Sale18.006,000108,000165,368Feb 14 04:33 PM
Traynor Richard M.SVP AND GENERAL COUNSELDec 26 '23Sale18.006,000108,000171,368Dec 27 06:36 PM